期刊文献+

Immune Control Strategies for Vaccinia Virus-related Laboratory-acquired Infections 被引量:3

Immune Control Strategies for Vaccinia Virus-related Laboratory-acquired Infections
下载PDF
导出
摘要 While presenting biological characteristics of vaccinia virus and laboratory-acquired infections during related research processes, this paper focuses on benefits and risks of vaccinia virus immunization in relation to laboratory-acquired infections, describes characteristics and the adaptation of vaccinia virus vaccine, analyses the role vaccinia virus immunization plays in the prevention and control of laboratory-acquired infections, and finally proposes solutions and countermeasures to further promote and implement immune control strategies. The problem related to immune strategy and laboratory- acquired infections which is being raised, analyzed and explored plays an active and instructive role in vaccinia virus related researches and laboratory- acquired infections, and also helps to recommend and develop relevant immune strategy for future vaccine control of such infections. While presenting biological characteristics of vaccinia virus and laboratory-acquired infections during related research processes, this paper focuses on benefits and risks of vaccinia virus immunization in relation to laboratory-acquired infections, describes characteristics and the adaptation of vaccinia virus vaccine, analyses the role vaccinia virus immunization plays in the prevention and control of laboratory-acquired infections, and finally proposes solutions and countermeasures to further promote and implement immune control strategies. The problem related to immune strategy and laboratory- acquired infections which is being raised, analyzed and explored plays an active and instructive role in vaccinia virus related researches and laboratory- acquired infections, and also helps to recommend and develop relevant immune strategy for future vaccine control of such infections.
出处 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2014年第2期142-146,共5页 生物医学与环境科学(英文版)
基金 supported by the National Health and Family Planning Commission(201302006)
  • 相关文献

参考文献1

二级参考文献40

  • 1Artenstein AW,Johnson C,Marbury TC,et al.A novel,cell cuhure-derived smallpox vaccine in vaccinia-naive adults[J].Vaccine,2005,23(25):3301-3309. 被引量:1
  • 2Greenberg RN,Kennedy JS,Clanton DJ,et al.Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine:a blind,single-centre,randomized controlled trial[J].Lancet,2005,365(9457):398-409. 被引量:1
  • 3Weltzin R,Liu J,Pugachev KV,et al.Clonal vaccinia virus grown in cell culture as a new smallpox vaccine[J].Nat Med,2003,9(9):1125-1130. 被引量:1
  • 4赵铠.天花疫苗[M] //赵铠,章以浩,李河民.医学生物制品学.2版.北京:人民卫生出版社,2007:963-972. 被引量:1
  • 5Kenner J,Cameron F,Empig C,et al.LC16m8:an attenuated smallpox vaccine[J].Vaccine,2006,24(47/48):7009-7022. 被引量:1
  • 6Wiser I,Balicer RD,Cohen D.An update on smallpox vaccine candidates and their role in bioterrorism related vaccination straegies[J].Vaccine,2007,25(6):976-984. 被引量:1
  • 7Fujii T,Kannatani Y,Matsumura T,et al.Clinical evaluation of attenuated smallpox vaccine LC16m8 in Japan[C] // 2006ASM Biodefense Research Meeting,Washington,DC,2006.Washington,DC:American Society for Microbiology,2006:65. 被引量:1
  • 8McCurdy LH,Larkin BD,Martin JE,et al.Modified vaccinia Ankara:potential as an alternative smallpox vaccine[J].Clin Infect Dis,2004,38(12):1749-1753. 被引量:1
  • 9Wyatt LS,Earl PL,Eller LA,et al.Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge[J].Proc Natl Acad Sci U S A,2004,101(13):4590-4595. 被引量:1
  • 10Earl PL,Americo JL,Wyatt LS,et al.Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox[J].Nature,2004,428(6979):182-185. 被引量:1

共引文献1

同被引文献25

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部